Holen Sie sich die Stockscreener-App
1.80
4.96%
0.085
Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
33.25%
3.639
|
5.452 | 6.721 | 8.622 | 10.26 |
| Interest Income/Expense |
1.75%
0.872
|
0.857 | 0.841 | 0.82 | 0.036 |
| Operating Income/Loss |
24.09%
-10.48
|
-13.80 | -15.36 | -16.44 | -15.50 |
| Income/Loss From Continuing Operations Before Tax |
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
| Income/Loss From Continuing Operations After Tax |
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
Net Income/Loss
|
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
34.37%
-0.21
|
-0.32 | -0.35 | -0.37 | -0.35 |
| Diluted Earnings Per Share |
34.37%
-0.21
|
-0.32 | -0.35 | -0.37 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):